VolitionRx Limited VNRX
$ 0.67
15.96%
Quarterly report 2024-Q3
added 11-14-2024
Country |
Singapore |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NYSE AMERICAN |
CEO |
Mr. Cameron Reynolds |
Employees in the company |
50 |
Shares |
81.9 M |
Market Cap[1] |
$ 54.9 M |
EBITDA (LTM) |
$ -31.8 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.